Dr. Maria Anitan to present at WDSC in Boston
If you are attending the World Drug Safety Congress Americas in Boston October 18-19, be sure to check out the talk our global head of pharmacovigilance and drug safety, Dr. Maria Anitan, is giving on data protection aspects to consider when establishing global pharmacovigilance systems. Dr. Anitan is an experienced pharmaceutical industry professional with more than 20 years of industry experience, including more than 15 years in leadership roles covering pharmacovigilance, medical affairs, healthcare compliance, and GDPR, which she has practiced in the United States and Europe. She has held different positions in Eli Lilly, Genzyme-Sanofi, UCB, and Ipsen, and has worked on multiple cross-functional projects in the areas of rare diseases, neurology, oncology, bone marrow transplant, and hematology. She is a subject matter expert for pharmacovigilance issues, regulatory interpretation and best practices, and management of safety data and analysis in both clinical trials and post-marketing around the world.
Let us know if you plan to be at WDSC in Boston, and be sure to stop by Booth 411 and say hi during the meeting!
#WorldDrugSafetyCongressAmericas #WDSC #Pharmacovigilance #DrugSafety #dataprotection #pvcompliance